Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1973-08-09
1976-02-17
Padgett, Benjamin R.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
2523011R, A61K 4300
Patent
active
039392589
ABSTRACT:
A process for the manufacture of human transferrin labelled with indium 113 m is provided, wherein an acid eluate of an indium 113 m generator having an activity concentration of 0.1 to 50 m Curie per ml is added dropwise to an aqueous solution containing 3 to 10 mg of sodium bicarbonate per 5 to 100 mg of human transferrin per ml. The solution may also contain hydrochloric acid or sodium chloride and a bacteriostatic agent.
REFERENCES:
"Red Cell and Plasma Protein Labeling with .sup.113m In," International Journal of Applied Radiation and Isotopes, 1971, Vol. 22, No. 8, pp. 498-501.
Chemical Abstracts, Vol. 75, No. 19, Nov. 8, 1971, p. 78, Item No. 116531b.
Chemical Abstracts, Vol. 72, No. 15, Apr. 13, 1970, p. 85, Item No. 75562e.
Hoechst Aktiengesellschaft
Nucker Christine M.
Padgett Benjamin R.
LandOfFree
Process for the manufacture of human transferrin labelled with i does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Process for the manufacture of human transferrin labelled with i, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for the manufacture of human transferrin labelled with i will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1746969